Nick Stockton writes at Wired:
We’ll get into that, I promise, but first let’s review what Theranos is. The company is aiming to offer more than 200 blood tests at prices less than half the Medicare reimbursement rate.
The Washington Post writes:
When Theranos chose to publish its entire list of test prices online, with average prices set at half the Medicare reimbursement rates, the public took notice.
Is that claim true? Does Theranos charge less than half of the Medicare reimbursement rate?
